Next Article in Journal
Comparison of Different Nutritional Assessment Tools in Detecting Malnutrition and Sarcopenia among Cirrhotic Patients
Next Article in Special Issue
Malignant Clinical Course of “Proliferative” Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls
Previous Article in Journal
MRI Appearance of Focal Lesions in Liver Iron Overload
Previous Article in Special Issue
GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice

1
Pathology Unit, Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy
2
Pathology Unit, Department of Health Sciences, Università del Piemonte Orientale (UPO), 28100 Novara, Italy
3
Pathology Unit, Department of Translational Medicine, “Sant’Andrea” Hospital, Università del Piemonte Orientale (UPO), 13100 Vercelli, Italy
4
Radiology Department, Umberto I Mauriziano Hospital, 10128 Turin, Italy
*
Author to whom correspondence should be addressed.
Submission received: 12 February 2022 / Revised: 17 March 2022 / Accepted: 29 March 2022 / Published: 2 April 2022

Abstract

:
A 66-year-old man presented with a 2.8 cm lesion of the left vocal cord. On contrast-enhanced computed tomography scans, the tumor extended to the supraglottis, subglottis, paraglottic space and anterior commissure, causing partial obstruction of the laryngeal lumen. At another hospital, a fragmented incisional biopsy was diagnosed as a granular cell tumor, as to the S-100 immunohistochemical positivity. After excision, the tumor revealed to be an adult-type laryngeal rhabdomyoma. The typical cytoplasmic rod-like inclusions and cross striations were more evident in the second specimen. We confirmed the unusual S-100 immunohistochemical positivity (variable intensity, >90% of tumor cells). Muscle markers were not performed on the previous biopsy, resulting positive in our specimen (Desmin: strong, diffuse expression; Smooth Muscle Actin: strong staining in 10% of tumor cells). Melan-A, CD68, GFAP, pan-cytokeratins, CEA, calretinin and neurofilaments resulted negative. To our brief, systematic literature review, S-100 positivity (usually variable, often weak or patchy/focal) was globally found in 19/34 (56%) adult-type rhabdomyomas of the head and neck region. Especially on fragmented biopsy material, the differential diagnoses of laryngeal rhabdomyomas may include granular cell tumors, oncocytic tumors of the salivary glands or of different origin, and paragangliomas.

Figure 1. A 66-year-old man presented with a previous diagnosis of granular cell tumor of the left vocal cord on an incisional biopsy performed at another hospital. Contrast-enhanced computed tomography revealed a soft tissue mass of 2.8 × 2.5 × 1.1 cm of the left vocal cord, with transglottic extension, spreading to the supraglottis, subglottis, paraglottic space and the anterior commissure, causing partial obstruction of the laryngeal lumen; no infiltration of the cartilage was evident (computed tomography scans; (A): coronal plane, (B): axial plane; previously unpublished, original photos).
Figure 1. A 66-year-old man presented with a previous diagnosis of granular cell tumor of the left vocal cord on an incisional biopsy performed at another hospital. Contrast-enhanced computed tomography revealed a soft tissue mass of 2.8 × 2.5 × 1.1 cm of the left vocal cord, with transglottic extension, spreading to the supraglottis, subglottis, paraglottic space and the anterior commissure, causing partial obstruction of the laryngeal lumen; no infiltration of the cartilage was evident (computed tomography scans; (A): coronal plane, (B): axial plane; previously unpublished, original photos).
Diagnostics 12 00892 g001
Figure 2. An excisional biopsy was performed. On gross exam, the lesion had a hemorrhagic appearance. Histological examination revealed a highly cellular tumor (upper part of the Figure), involving the subepithelial connective tissue, with extensive superficial de-epithelization (arrow: residual squamous epithelium of the vocal cord). The lesion was unencapsulated and mainly well-delimited from the underlying striated muscle layer (lower part of the Figure), with pushing growth borders; however, the partial fragmentation of the material did not allow a complete definition of the tumor growth front. The surgical margins were involved, while biopsies of the bilateral false vocal cords were unaffected (Hematoxylin and Eosin, 4×; previously unpublished, original photo).
Figure 2. An excisional biopsy was performed. On gross exam, the lesion had a hemorrhagic appearance. Histological examination revealed a highly cellular tumor (upper part of the Figure), involving the subepithelial connective tissue, with extensive superficial de-epithelization (arrow: residual squamous epithelium of the vocal cord). The lesion was unencapsulated and mainly well-delimited from the underlying striated muscle layer (lower part of the Figure), with pushing growth borders; however, the partial fragmentation of the material did not allow a complete definition of the tumor growth front. The surgical margins were involved, while biopsies of the bilateral false vocal cords were unaffected (Hematoxylin and Eosin, 4×; previously unpublished, original photo).
Diagnostics 12 00892 g002
Figure 3. The tumor was composed of large polygonal cells of variable size and shape, with abundant granular eosinophilic cytoplasm; vacuolated cells (spider cells) were usually dispersed through the tumor (A), occasionally concentrated in some areas (B). Vascularization included small, sometimes dilated capillaries and occasional ectatic medium-sized vessels (Hematoxylin and Eosin, 10×; previously unpublished, original photos).
Figure 3. The tumor was composed of large polygonal cells of variable size and shape, with abundant granular eosinophilic cytoplasm; vacuolated cells (spider cells) were usually dispersed through the tumor (A), occasionally concentrated in some areas (B). Vascularization included small, sometimes dilated capillaries and occasional ectatic medium-sized vessels (Hematoxylin and Eosin, 10×; previously unpublished, original photos).
Diagnostics 12 00892 g003
Figure 4. Nuclear atypia was absent to mild. Indeed, the large- to medium-sized tumor cells showed relatively monomorphic, peripherally or centrally located, vesicular nuclei of small to medium size; the chromatin was fine, despite occasional slight variation in nuclear size and shape, with irregularities of nuclear membranes and rare multinucleations. The nucleoli were occasionally evident, but small. Pleomorphism, mitoses and necrosis were absent. The intercellular stroma was almost virtual in the majority of the tumor, but loose connective tissue (no desmoplasia) was found in less-cellular areas (like this one) (Hematoxylin and Eosin, 20×; previously unpublished, original photo).
Figure 4. Nuclear atypia was absent to mild. Indeed, the large- to medium-sized tumor cells showed relatively monomorphic, peripherally or centrally located, vesicular nuclei of small to medium size; the chromatin was fine, despite occasional slight variation in nuclear size and shape, with irregularities of nuclear membranes and rare multinucleations. The nucleoli were occasionally evident, but small. Pleomorphism, mitoses and necrosis were absent. The intercellular stroma was almost virtual in the majority of the tumor, but loose connective tissue (no desmoplasia) was found in less-cellular areas (like this one) (Hematoxylin and Eosin, 20×; previously unpublished, original photo).
Diagnostics 12 00892 g004
Figure 5. On higher power, cytoplasmic rod-like inclusions and often subtle cross striations were present in many cells ((AC); Hematoxylin and Eosin, 20×; previously unpublished, original photos), being more subtle in some areas (as in Figure 5A). Periodic Acid–Schiff (PAS) stain showed variable cytoplasmic positivity ((D); 10×; previously unpublished, original photo), while PAS-diastase reaction resulted negative.
Figure 5. On higher power, cytoplasmic rod-like inclusions and often subtle cross striations were present in many cells ((AC); Hematoxylin and Eosin, 20×; previously unpublished, original photos), being more subtle in some areas (as in Figure 5A). Periodic Acid–Schiff (PAS) stain showed variable cytoplasmic positivity ((D); 10×; previously unpublished, original photo), while PAS-diastase reaction resulted negative.
Diagnostics 12 00892 g005
Figure 6. As the case had the morphological features of an adult-type rhabdomyoma (RM), previous slides were retrieved. Rod-like inclusions and cross striations were less evident and the material was fragmented; S-100 immunohistochemical expression was previously reported. Indeed, S-100 positivity was confirmed in >90% of tumor cells in our specimen, which showed a variable (weak to strong) intensity of cytoplasmic and nuclear staining (Figure 6; 10×; clone 4C4.9, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; previously unpublished, original photo).
Figure 6. As the case had the morphological features of an adult-type rhabdomyoma (RM), previous slides were retrieved. Rod-like inclusions and cross striations were less evident and the material was fragmented; S-100 immunohistochemical expression was previously reported. Indeed, S-100 positivity was confirmed in >90% of tumor cells in our specimen, which showed a variable (weak to strong) intensity of cytoplasmic and nuclear staining (Figure 6; 10×; clone 4C4.9, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; previously unpublished, original photo).
Diagnostics 12 00892 g006
Figure 7. Additional markers had been previously performed, including melan-A (clone A103, mouse monoclonal, Ventana), CD68 (clones KP-1 and PG-M1, mouse monoclonal, Ventana), GFAP (clone 6F2, mouse monoclonal, Dako, Agilent Technologies, Santa Clara, CA, USA), pan-cytokeratins (clone AE1/AE3, mouse monoclonal, Dako), CEA (clone TF 3H8-1, mouse monoclonal, Ventana), calretinin (clone SP65, rabbit monoclonal, Ventana) and neurofilaments; they all resulted negative. Desmin and smooth muscle actin (SMA) were simultaneously tested in both our current and previous specimen; desmin resulted strongly positive in >98% of tumor cells ((A); clone DE-R-11, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; 10×; previously unpublished, original photo), while SMA was strongly expressed by 10% of RM cells (patchy positivity, mainly around capillaries/medium vessels) ((B); clone 1A4, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; 10×; previously unpublished, original photo). Finally, the proliferation index (Ki-67, clone 30-9, rabbit monoclonal, Ventana) was <1%. A diagnosis of an adult-type RM of the vocal cord was made. RMs are rare tumors showing skeletal muscle differentiation, distinguished as of adult (the most common), fetal, or genital type; this classification is usually done according to morphological features, despite there being a site and age predilection for each subtype [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. By definition, genital RMs arise from the genitalia (vagina, vulva, cervix, paratesticular, epididymis, spermatic cord, etc.) of both sexes (8–67 years of age), entering in the differential diagnosis with various benign and malignant tumors [1,5,16,33]; on the other hand, most cases of the other two types arise in the head and neck region (pharynx, larynx, paratracheal, salivary glands, oral cavity, submandibular, soft tissues, etc.) and rarely from extremities or visceral organs (heart, bladder, stomach, etc.), with a slight male predominance [1,2,3,4,6,15,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. The adult-type is the most common form (median age: 60 years; range 33–80 years), and has a male predominance [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. Fetal RMs frequently occur in the postauricular region of newborns/children and can be associated with basal cell nevus syndrome; this syndrome is caused by PTCH1 mutations, which can activate the hedgehog signaling [1,10,13,32,34,35]. Non-syndromic, fetal or adult RMs may also show activation of this pathway [1,34,35]. Extracardiac RMs have also been associated to Birt–Hogg–Dubé syndrome (caused by FLCN mutations), while cardiac rhabomyomas frequently occur in the Tuberous Sclerosis setting [1,4,6,7,8,30]. Usually described as slow-growing, painless, soft, and well-circumscribed tumors (size range: 0.5–10 cm; median size: 3 cm), adult RMs are typically benign; however, worrisome features can occur, including fast growth, multifocality (3–15%) (while fetal RMs are usually solitary) or recurrence (10–40%), even in adequately excised tumors [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,34,35]. While adult RMs (as in our case) typically reveal large mature rhabdomyoblasts, with scattered spider cells, fetal RMs usually show irregular bundles of immature skeletal muscle fibers, featuring fetal myotubes (round or spindle cells with occasional cross striations) arranged in a myxoid background [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,34,35]. Fetal RMs can be further grouped into cellular (uniform population of differentiating myoblasts) or myxoid subtypes, depending on the predominant component; mitotic activity can be relatively increased (5/50 mm2), especially in this subtype, in the absence of nuclear atypia, infiltrative margins, atypical mitoses or necrosis [1,10,13,32,35]. In our case, mitoses and nuclear atypia were not found. Female genital RMs are relatively small and contain loose fibrous connective tissue with spindle, polygonal, or elongated rhabdomyoblasts; male genital tumors have histological features of adult or fetal RMs [1,5,16,33]. A granular cell tumor (GCT) was erroneously diagnosed, as the tumor cells, especially at low power, show a granular eosinophilic cytoplasm due to massive accumulation of lysosomes; moreover, typical rod-like inclusions and cross striations were less evident in the previous, partially fragmented specimen. However, the cells of GCTs are usually smaller and less polygonal than those of adult-type RMs; the cell borders are usually ill-defined, sometimes indistinct, and may produce a syncytial appearance. GCT is a rare, frequently benign tumor, frequently arising in the head and neck region (about 50% of cases), especially in the tongue (25% of all cases), while the larynx is less commonly involved (6–10%) [1,36,37,38,39,40]. Other sites include deep dermis/subcutis of trunk (including breast, 5–15%) and proximal extremities, where most of the bona fide malignant cases (50% risk of metastasis) usually occur (especially in thigh) [1,36,37,38,39,40]. Visceral organs (gastro-intestinal tract, etc.) can be involved as well [1,36,37,38,39,40]. Usually solitary, they can be multifocal (10%), also involving different organ sites [1,36,37,38,39,40]. Local recurrence can be seen after incomplete excision; it could also represent an adverse prognostic factor for malignant cases, together with metastatic behavior, larger tumor size, and old age [1]. The head and neck region is less frequently involved with malignant GCTs [36,37,39,40]. GCT patients are usually adults (3rd to 6th decades); the average age of diagnosis for laryngeal GCT is 36 years [1,36,37,38,39,40]. GCTs are generally reactive for S-100, SOX10, nestin, inhibin, calretinin, CD68, CD63 (NKI/C3), and NSE; staining for melan-A is a very rare event (typically focal reactivity), while HMB-45 is usually negative [1,36,40]. Congenital granular cell lesion/epulis is a rare, benign, S-100-negative lesion that is typical of the alveolar ridge (maxilla, mandible) of newborns; the larynx is not a typical site [41,42,43]. The diffuse S-100 positivity of this case was sufficient to support the misleading hypothesis of a GCT, while muscle markers were not performed in the previous specimen. Adult RMs are usually strongly and diffusely positive for desmin, while myogenin and actin can be variably/focally expressed, as in our case [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. Myoglobin, and MYOD1 can be positive as well [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. GFAP and S-100 immunohistochemical expression are rarely reported in RMs, typically being focally expressed [1,3,20,21,22,23,24,25,26,27,28,29,30,31,32]. To support this consideration, we performed a brief systematic literature review, searching for (S100 OR S-100) AND (rhabdomyoma OR rhabdomyomas) in Pubmed (27 results), Scopus (46 results) and Web of Science (18 results) databases. No limitations were set. Relevant articles were obtained in full-text format and screened for additional references. The bibliographic research ended on February 12, 2022. The main limitations of our review were represented by selection biases and by the possibility that not all the articles investigating S-100 expression in RMs could have been retrieved. However, including our case, S-100 positivity was globally found in 19/34 (56%) adult-type RMs of the head and neck region [3,20,21,22,23,24,25,26,27,28,29,30,31,32]. The larger series was that of Kapadia et al. [26], who reported variable (often weak) S-100 positivity in 14/21 (67%) cases (rabbit polyclonal antibody, Dako, 1:1600 dilution). In the remaining four previously reported cases, the positivity was observed in some cells or few scattered nuclei, or it was unclear; the antibody clones were usually not reported [22,28,30,31]. Conversely, S-100 expression was confirmed in >90% of tumor cells in our case, with variable (weak to strong) intensity of staining. Finally, Kapadia et al. [32] reported that also 6/12 (50%) fetal-type RMs of the head and neck region resulted positive for S-100 (1–2+ on a scale ranging from 0 to 4, where 1+ was focal pale positivity); the antibody clone was unclear. These authors additionally specified that 5/6 (83%) cases showed S-100 expression in less differentiated (more primitive-looking), round to oval, mesenchymal cells, while there was diffuse, weak staining of the skeletal muscle fibers in the remaining case; however, it did not reach a 4+ (diffuse, intense) score [32]. Finally, especially on small biopsy material or cytologic samples taken from accessible sites, rare differential diagnoses of RMs may also include: (1) oncocytic tumors (not only oncocytomas) of the salivary glands, usually arising from the parotid, but rarely from minor salivary glands of various sites (including larynx); (2) oncocytic tumors of other origins (such as metastatic renal cell carcinoma); (3) paragangliomas (rarely involving the larynx) [44,45,46,47,48,49,50]. Oncocytomas are composed of tumor cells with abundant granular eosinophilic cytoplasm and vesicular to pyknotic nuclei, while paragangliomas show epithelioid, spindle and/or plasmocytoid cells (ovoid nuclei, fine chromatin, and inconspicuous nucleoli), arranged as single cells or in sheets [44,47,48,49]. Both tumors are typically negative for striated muscle markers, although they may occasionally show S-100 positivity (not typical) [44,47,48,49]. In conclusion, the increasing implementation of various immunohistochemical biomarkers in different tumor contexts has made wider diagnostic immunopanels available for the pathologists’ routine practice. Indeed, proper historical and novel immunostains should be tested without discounts, when indicated, to achieve the correct diagnosis, excluding other relevant differential diagnoses. Moreover, immunomarkers performed to exclude particular hypotheses may reveal unexpected results, helping to consider previously excluded or not evaluated entities. Conversely, the widespread use of inappropriate immunomarkers may result in increasing the diagnostic difficulties, in case of unpredictable results, that cannot be easily managed. The infrequent positivity of some markers in rarely tested tumors (such as S-100 in RMs) may represent misleading diagnostic pitfalls, especially when all the differential diagnoses have not been properly considered [47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64]. Morphology should be accurately evaluated, and a second opinion may be asked.
Figure 7. Additional markers had been previously performed, including melan-A (clone A103, mouse monoclonal, Ventana), CD68 (clones KP-1 and PG-M1, mouse monoclonal, Ventana), GFAP (clone 6F2, mouse monoclonal, Dako, Agilent Technologies, Santa Clara, CA, USA), pan-cytokeratins (clone AE1/AE3, mouse monoclonal, Dako), CEA (clone TF 3H8-1, mouse monoclonal, Ventana), calretinin (clone SP65, rabbit monoclonal, Ventana) and neurofilaments; they all resulted negative. Desmin and smooth muscle actin (SMA) were simultaneously tested in both our current and previous specimen; desmin resulted strongly positive in >98% of tumor cells ((A); clone DE-R-11, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; 10×; previously unpublished, original photo), while SMA was strongly expressed by 10% of RM cells (patchy positivity, mainly around capillaries/medium vessels) ((B); clone 1A4, mouse monoclonal, Ventana Medical Systems, Oro Valley, AZ, USA; 10×; previously unpublished, original photo). Finally, the proliferation index (Ki-67, clone 30-9, rabbit monoclonal, Ventana) was <1%. A diagnosis of an adult-type RM of the vocal cord was made. RMs are rare tumors showing skeletal muscle differentiation, distinguished as of adult (the most common), fetal, or genital type; this classification is usually done according to morphological features, despite there being a site and age predilection for each subtype [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. By definition, genital RMs arise from the genitalia (vagina, vulva, cervix, paratesticular, epididymis, spermatic cord, etc.) of both sexes (8–67 years of age), entering in the differential diagnosis with various benign and malignant tumors [1,5,16,33]; on the other hand, most cases of the other two types arise in the head and neck region (pharynx, larynx, paratracheal, salivary glands, oral cavity, submandibular, soft tissues, etc.) and rarely from extremities or visceral organs (heart, bladder, stomach, etc.), with a slight male predominance [1,2,3,4,6,15,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. The adult-type is the most common form (median age: 60 years; range 33–80 years), and has a male predominance [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. Fetal RMs frequently occur in the postauricular region of newborns/children and can be associated with basal cell nevus syndrome; this syndrome is caused by PTCH1 mutations, which can activate the hedgehog signaling [1,10,13,32,34,35]. Non-syndromic, fetal or adult RMs may also show activation of this pathway [1,34,35]. Extracardiac RMs have also been associated to Birt–Hogg–Dubé syndrome (caused by FLCN mutations), while cardiac rhabomyomas frequently occur in the Tuberous Sclerosis setting [1,4,6,7,8,30]. Usually described as slow-growing, painless, soft, and well-circumscribed tumors (size range: 0.5–10 cm; median size: 3 cm), adult RMs are typically benign; however, worrisome features can occur, including fast growth, multifocality (3–15%) (while fetal RMs are usually solitary) or recurrence (10–40%), even in adequately excised tumors [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,34,35]. While adult RMs (as in our case) typically reveal large mature rhabdomyoblasts, with scattered spider cells, fetal RMs usually show irregular bundles of immature skeletal muscle fibers, featuring fetal myotubes (round or spindle cells with occasional cross striations) arranged in a myxoid background [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,34,35]. Fetal RMs can be further grouped into cellular (uniform population of differentiating myoblasts) or myxoid subtypes, depending on the predominant component; mitotic activity can be relatively increased (5/50 mm2), especially in this subtype, in the absence of nuclear atypia, infiltrative margins, atypical mitoses or necrosis [1,10,13,32,35]. In our case, mitoses and nuclear atypia were not found. Female genital RMs are relatively small and contain loose fibrous connective tissue with spindle, polygonal, or elongated rhabdomyoblasts; male genital tumors have histological features of adult or fetal RMs [1,5,16,33]. A granular cell tumor (GCT) was erroneously diagnosed, as the tumor cells, especially at low power, show a granular eosinophilic cytoplasm due to massive accumulation of lysosomes; moreover, typical rod-like inclusions and cross striations were less evident in the previous, partially fragmented specimen. However, the cells of GCTs are usually smaller and less polygonal than those of adult-type RMs; the cell borders are usually ill-defined, sometimes indistinct, and may produce a syncytial appearance. GCT is a rare, frequently benign tumor, frequently arising in the head and neck region (about 50% of cases), especially in the tongue (25% of all cases), while the larynx is less commonly involved (6–10%) [1,36,37,38,39,40]. Other sites include deep dermis/subcutis of trunk (including breast, 5–15%) and proximal extremities, where most of the bona fide malignant cases (50% risk of metastasis) usually occur (especially in thigh) [1,36,37,38,39,40]. Visceral organs (gastro-intestinal tract, etc.) can be involved as well [1,36,37,38,39,40]. Usually solitary, they can be multifocal (10%), also involving different organ sites [1,36,37,38,39,40]. Local recurrence can be seen after incomplete excision; it could also represent an adverse prognostic factor for malignant cases, together with metastatic behavior, larger tumor size, and old age [1]. The head and neck region is less frequently involved with malignant GCTs [36,37,39,40]. GCT patients are usually adults (3rd to 6th decades); the average age of diagnosis for laryngeal GCT is 36 years [1,36,37,38,39,40]. GCTs are generally reactive for S-100, SOX10, nestin, inhibin, calretinin, CD68, CD63 (NKI/C3), and NSE; staining for melan-A is a very rare event (typically focal reactivity), while HMB-45 is usually negative [1,36,40]. Congenital granular cell lesion/epulis is a rare, benign, S-100-negative lesion that is typical of the alveolar ridge (maxilla, mandible) of newborns; the larynx is not a typical site [41,42,43]. The diffuse S-100 positivity of this case was sufficient to support the misleading hypothesis of a GCT, while muscle markers were not performed in the previous specimen. Adult RMs are usually strongly and diffusely positive for desmin, while myogenin and actin can be variably/focally expressed, as in our case [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. Myoglobin, and MYOD1 can be positive as well [1,2,3,4,9,20,21,22,23,24,25,26,27,28,29,30,31]. GFAP and S-100 immunohistochemical expression are rarely reported in RMs, typically being focally expressed [1,3,20,21,22,23,24,25,26,27,28,29,30,31,32]. To support this consideration, we performed a brief systematic literature review, searching for (S100 OR S-100) AND (rhabdomyoma OR rhabdomyomas) in Pubmed (27 results), Scopus (46 results) and Web of Science (18 results) databases. No limitations were set. Relevant articles were obtained in full-text format and screened for additional references. The bibliographic research ended on February 12, 2022. The main limitations of our review were represented by selection biases and by the possibility that not all the articles investigating S-100 expression in RMs could have been retrieved. However, including our case, S-100 positivity was globally found in 19/34 (56%) adult-type RMs of the head and neck region [3,20,21,22,23,24,25,26,27,28,29,30,31,32]. The larger series was that of Kapadia et al. [26], who reported variable (often weak) S-100 positivity in 14/21 (67%) cases (rabbit polyclonal antibody, Dako, 1:1600 dilution). In the remaining four previously reported cases, the positivity was observed in some cells or few scattered nuclei, or it was unclear; the antibody clones were usually not reported [22,28,30,31]. Conversely, S-100 expression was confirmed in >90% of tumor cells in our case, with variable (weak to strong) intensity of staining. Finally, Kapadia et al. [32] reported that also 6/12 (50%) fetal-type RMs of the head and neck region resulted positive for S-100 (1–2+ on a scale ranging from 0 to 4, where 1+ was focal pale positivity); the antibody clone was unclear. These authors additionally specified that 5/6 (83%) cases showed S-100 expression in less differentiated (more primitive-looking), round to oval, mesenchymal cells, while there was diffuse, weak staining of the skeletal muscle fibers in the remaining case; however, it did not reach a 4+ (diffuse, intense) score [32]. Finally, especially on small biopsy material or cytologic samples taken from accessible sites, rare differential diagnoses of RMs may also include: (1) oncocytic tumors (not only oncocytomas) of the salivary glands, usually arising from the parotid, but rarely from minor salivary glands of various sites (including larynx); (2) oncocytic tumors of other origins (such as metastatic renal cell carcinoma); (3) paragangliomas (rarely involving the larynx) [44,45,46,47,48,49,50]. Oncocytomas are composed of tumor cells with abundant granular eosinophilic cytoplasm and vesicular to pyknotic nuclei, while paragangliomas show epithelioid, spindle and/or plasmocytoid cells (ovoid nuclei, fine chromatin, and inconspicuous nucleoli), arranged as single cells or in sheets [44,47,48,49]. Both tumors are typically negative for striated muscle markers, although they may occasionally show S-100 positivity (not typical) [44,47,48,49]. In conclusion, the increasing implementation of various immunohistochemical biomarkers in different tumor contexts has made wider diagnostic immunopanels available for the pathologists’ routine practice. Indeed, proper historical and novel immunostains should be tested without discounts, when indicated, to achieve the correct diagnosis, excluding other relevant differential diagnoses. Moreover, immunomarkers performed to exclude particular hypotheses may reveal unexpected results, helping to consider previously excluded or not evaluated entities. Conversely, the widespread use of inappropriate immunomarkers may result in increasing the diagnostic difficulties, in case of unpredictable results, that cannot be easily managed. The infrequent positivity of some markers in rarely tested tumors (such as S-100 in RMs) may represent misleading diagnostic pitfalls, especially when all the differential diagnoses have not been properly considered [47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64]. Morphology should be accurately evaluated, and a second opinion may be asked.
Diagnostics 12 00892 g007

Author Contributions

Conceptualization, A.P. and A.R.; methodology, A.P.; software, A.P.; validation, A.B.M., G.V. and R.B.; formal analysis, A.R. and M.Z.; investigation, A.R., A.B.M. and A.P.; resources, A.P.; data curation, A.P.; writing—original draft preparation, A.P., A.R. and M.Z.; writing—review and editing, G.V. and R.B.; visualization, A.R.; supervision, M.Z.; project administration, R.B.; funding acquisition, M.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study, due to the description of a single case.

Informed Consent Statement

Patient gave informed consent for treatment of anonymous data.

Acknowledgments

Andrea Palicelli thanks his family for personal support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours, 5th ed.; IARC: Lyon, France, 2020; pp. 1–607.
  2. Pavlov, P.; Kiseleva, K.; Zakharova, M.; Hashimli, R. Rhabdomyoma of the Larynx in a Child with Recurrent Airway Problems. Turk. Arch. Otorhinolaryngol. 2020, 58, 137–140. [Google Scholar] [CrossRef] [PubMed]
  3. Khalaf, M.G.; Haddad, R.; Akiki, M.; Khazen, J.; Melkane, A.E. Multifocal adult rhabdomyoma of the head and neck: Case report and systematic review of the literature. Int. J. Oral. Maxillofac. Surg. 2021, 50, 327–334. [Google Scholar] [CrossRef] [PubMed]
  4. Black, M.; Wei, X.J.; Sun, W.; Simms, A.; Negron, R.; Hagiwara, M.; Chidakel, A.R.; Hodak, S.; Persky, M.S.; Shi, Y. Adult rhabdomyoma presenting as thyroid nodule on fine-needle aspiration in patient with Birt-Hogg-Dubé syndrome: Case report and literature review. Diagn. Cytopathol. 2020, 48, 576–580. [Google Scholar] [CrossRef] [PubMed]
  5. Huesmann, S.T.; Wiegand, M.; Barth, T.F.; Mian, E.; Widschwendter, P.; Janni, W.; Hancke, K. Case Report and Review of the Literature of a Rare Entity of a Uterine Fibroid: A Genital Rhabdomyoma. Int. J. Gynecol. Pathol. 2021, 40, 97–101. [Google Scholar] [CrossRef] [PubMed]
  6. Sarkar, S.; Siddiqui, W.J. Cardiac Rhabdomyoma; StatPearls Publishing: Treasure Island, FL, USA, 2021. [Google Scholar]
  7. Neri, M.; Di Donato, S.; Maglietta, R.; Pomara, C.; Riezzo, I.; Turillazzi, E.; Fineschi, V. Sudden death as presenting symptom caused by cardiac primary multicentric left ventricle rhabdomyoma, in an 11-month-old baby. An immunohistochemical study. Diagn. Pathol. 2012, 7, 169. [Google Scholar] [CrossRef] [Green Version]
  8. Burke, A.P.; Virmani, R. Cardiac rhabdomyoma: A clinicopathologic study. Mod. Pathol. 1991, 4, 70–74. [Google Scholar]
  9. Stein, A.P.; Weidenbecher, M. Extracardiac Rhabdomyoma of the Larynx. Ear Nose Throat J. 2020, 99, 177–178. [Google Scholar] [CrossRef]
  10. González-Pérez, L.; Alvarez-Argüelles, H.; Ramos Gutiérrez, V.J.; Hernández, S.G.; Plata Bello, A.C.; Concepción Masip, T.; Salido Ruiz, E. Bladder Fetal Rhabdomyoma Intermediate Type. Urol. Int. 2018, 101, 240–244. [Google Scholar] [CrossRef]
  11. Morra, M.N.; Manson, A.L.; Gavrell, G.J.; Quinn, A.D. Rhabdomyoma of prostate. Urology 1992, 39, 271–273. [Google Scholar] [CrossRef]
  12. Tuazon, R. Rhabdomyoma of the stomach. Report of a case. Am. J. Clin. Pathol. 1969, 52, 37–41. [Google Scholar] [CrossRef]
  13. Wolfe, E.; Kowalik, C.; Sethapati, V.R.; Meister, M.R. Rare periurethral fetal rhabdomyoma presenting as a vaginal mass. Int. Urogynecol. J. 2021, 32, 3095–3097. [Google Scholar] [CrossRef] [PubMed]
  14. Sagar, N.; Mandal, S.; Khurana, N.; Kumar, A. Cervical rhabdomyoma a rare entity: Case report with review of literature. Indian J. Pathol. Microbiol. 2020, 63, 467–469. [Google Scholar] [CrossRef] [PubMed]
  15. Attafi, S.; Boujelbene, N.; Abbes, I.; Doghri, R.; Ben Hamida, N.; Ghorbel, R.; Charfi, L.; Driss, M.; Mrad, K. Vaginal rhabdomyoma: A case report of an uncommon and misleading neoplasm. Pathologica 2017, 109, 382–383. [Google Scholar] [PubMed]
  16. Schoolmeester, J.K.; Xing, D.; Keeney, G.L.; Sukov, W.R. Genital Rhabdomyoma of the Lower Female Genital Tract: A Study of 12 Cases with Molecular Cytogenetic Findings. Int. J. Gynecol. Pathol. 2018, 37, 349–355. [Google Scholar] [CrossRef] [PubMed]
  17. Jo, V.Y.; Reith, J.D.; Coindre, J.M.; Fletcher, C.D. Paratesticular rhabdomyoma: A morphologically distinct sclerosing variant. Am. J. Surg. Pathol. 2013, 37, 1737–1742. [Google Scholar] [CrossRef]
  18. Han, Y.; Qiu, X.S.; Li, Q.C.; Han, Y.C.; Lin, X.Y.; Zhang, Q.F.; Wang, J.; Wang, E.H.; Li, Z.L. Epididymis rhabdomyoma: A case report and literature review. Diagn. Pathol. 2012, 7, 47. [Google Scholar] [CrossRef] [Green Version]
  19. Maheshkumar, P.; Berney, D.M. Spermatic cord rhabdomyoma. Urology 2000, 56, 331. [Google Scholar] [CrossRef]
  20. Altissimi, G.; Ralli, M.; Sementilli, G.; Fiorentino, F.; Ciofalo, A.; Greco, A.; de Vincentiis, M.; Corsi, A.; Cianfrone, G. Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location. Case Rep. Otolaryngol. 2017, 2017, 7186768. [Google Scholar] [CrossRef] [Green Version]
  21. Dermawan, J.K.; Doxtader, E.; Chute, D.J.; Policarpio-Nicolas, M.L. Cytologic findings of an adult rhabdomyoma in the parapharyngeal space: A report of a case and review of the literature. Diagn. Cytopathol. 2018, 46, 419–424. [Google Scholar] [CrossRef]
  22. Souza, A.A.; de Araújo, V.C.; Passador Santos, F.; Ferreira Martinez, E.; de Menezes Filho, J.F.; Soares de Araujo, N.; Soares, A.B. Intraoral adult rhabdomyoma: A case report. Case Rep. Dent. 2013, 2013, 741548. [Google Scholar] [CrossRef] [Green Version]
  23. Jin, B.; Saleh, H. Pitfalls in the diagnosis of adult rhabdomyoma by fine needle aspiration: Report of a case and a brief literature review. Diagn. Cytopathol. 2009, 37, 483–486. [Google Scholar] [CrossRef] [PubMed]
  24. Hansen, T.; Burg, J.E.; Koutsimpelas, D.; Mann, W.J.; Kirkpatrick, C.J. Cervical adult rhabdomyoma presenting as a rapidly growing mass in a patient with diffuse large B-cell non-Hodgkin’s lymphoma. Mund. Kiefer. Gesichtschir. 2005, 9, 184–187. [Google Scholar] [CrossRef] [PubMed]
  25. Bastian, B.C.; Bröcker, E.B. Adult rhabdomyoma of the lip. Am. J. Dermatopathol. 1998, 20, 61–64. [Google Scholar] [CrossRef] [PubMed]
  26. Kapadia, S.B.; Meis, J.M.; Frisman, D.M.; Ellis, G.L.; Heffner, D.K.; Hyams, V.J. Adult rhabdomyoma of the head and neck: A clinicopathologic and immunophenotypic study. Hum. Pathol. 1993, 24, 608–617. [Google Scholar] [CrossRef]
  27. Sangueza, O.; Sangueza, P.; Jordan, J.; White, C.R., Jr. Rhabdomyoma of the tongue. Am. J. Dermatopathol. 1990, 12, 492–495. [Google Scholar] [CrossRef]
  28. Stewart, C.M.; Watson, R.E.; Eversole, L.R.; Fischlschweiger, W.; Leider, A.S. Oral granular cell tumors: A clinicopathologic and immunocytochemical study. Oral Surg. Oral Med. Oral Pathol. 1988, 65, 427–435. [Google Scholar] [CrossRef]
  29. McGregor, D.K.; Krishnan, B.; Green, L. Fine-needle aspiration of adult rhabdomyoma: A case report with review of the literature. Diagn. Cytopathol. 2003, 28, 92–95. [Google Scholar] [CrossRef]
  30. Balakumar, R.; Farr, M.R.B.; Fernando, M.; Jebreel, A.; Ray, J.; Sionis, S. Adult-Type Rhabdomyoma of the Larynx in Birt-Hogg-Dubé Syndrome: Evidence for a Real Association. Head Neck Pathol. 2019, 13, 507–511. [Google Scholar] [CrossRef] [Green Version]
  31. Dau, M.; Kraeft, S.K.; Kämmerer, P.W. Unique manifestation of a multifocal adult rhabdomyoma involving the soft palate-case report and review of literature. J. Surg. Case Rep. 2019, 2019, rjz116. [Google Scholar] [CrossRef]
  32. Kapadia, S.B.; Meis, J.M.; Frisman, D.M.; Ellis, G.L.; Heffner, D.K. Fetal rhabdomyoma of the head and neck: A clinicopathologic and immunophenotypic study of 24 cases. Hum. Pathol. 1993, 24, 754–765. [Google Scholar] [CrossRef]
  33. Palicelli, A.; Neri, P.; Marchioro, G.; De Angelis, P.; Bondonno, G.; Ramponi, A. Paratesticular seminoma: Echographic features and histological diagnosis with review of the literature. APMIS 2018, 126, 267–272. [Google Scholar] [CrossRef] [PubMed]
  34. Kerbrat, A.; Beaufrere, A.; Neiva-Vaz, C.; Galmiche, L.; Belhous, K.; Orbach, D.; Gauthier-Villars, M.; Picard, A.; Kadlub, N. Rhabdomyosarcoma and rhabdomyoma associated with nevoid basal cell carcinoma syndrome: Local treatment strategy. Pediatr. Dermatol. 2018, 35, e245–e247. [Google Scholar] [CrossRef] [PubMed]
  35. Hettmer, S.; Teot, L.A.; van Hummelen, P.; MacConaill, L.; Bronson, R.T.; Dall’Osso, C.; Mao, J.; McMahon, A.P.; Gruber, P.J.; Grier, H.E.; et al. Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J. Pathol. 2013, 231, 44–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Mur, T.A.; Pellegrini, W.R.; Tracy, L.F.; Levi, J.R. Laryngeal granular cell tumors in children: A literature review. Int. J. Pediatr. Otorhinolaryngol. 2020, 138, 110193. [Google Scholar] [CrossRef] [PubMed]
  37. Sataloff, R.T.; Ressue, J.C.; Portell, M.; Harris, R.M.; Ossoff, R.; Merati, A.L.; Zeitels, S. Granular cell tumors of the larynx. J. Voice 2000, 14, 119–134. [Google Scholar] [CrossRef]
  38. Leboulanger, N.; Rouillon, I.; Papon, J.F.; Josset, P.; Roger, G.; Garabédian, E.N. Childhood granular cell tumors: Two case reports. Int. J. Pediatr. Otorhinolaryngol. 2008, 72, 279–283. [Google Scholar] [CrossRef]
  39. Pelucchi, S.; Amoroso, C.; Grandi, E.; Carinci, F.; Pastore, A. Granular cell tumour of the larynx: Literature review and case report. J. Otolaryngol. 2002, 31, 234–235. [Google Scholar] [CrossRef]
  40. Lazar, R.H.; Younis, R.T.; Kluka, E.A.; Joyner, R.E.; Storgion, S. Granular cell tumor of the larynx: Report of two pediatric cases. Ear Nose Throat J. 1992, 71, 440–443. [Google Scholar] [CrossRef]
  41. Gan, J.; Shi, C.; Liu, S.; Tian, X.; Wang, X.; Ma, X.; Gao, P. Multiple congenital granular cell tumours of the maxilla and mandible: A rare case report and review of the literature. Transl. Pediatr. 2021, 10, 1386–1392. [Google Scholar] [CrossRef]
  42. Fliss, D.M.; Puterman, M.; Zirkin, H.; Leiberman, A. Granular cell lesions in head and neck: A clinicopathological study. J. Surg. Oncol. 1989, 42, 154–160. [Google Scholar] [CrossRef]
  43. Kaminecki, I.; Xu, W.; Abbas, S.H.; Kale, M. Newborn with a rare congenital granular cell lesion of the tongue. BMJ Case Rep. 2018, 11, e226777. [Google Scholar] [CrossRef] [PubMed]
  44. Robinson, A.C.; Kaberos, A.; Cox, P.M.; Stearns, M.P. Oncocytoma of the larynx. J. Laryngol. Otol. 1990, 104, 346–349. [Google Scholar] [CrossRef] [PubMed]
  45. Friedman, A.D.; Burns, J.A.; Lutch, M.J.; Zeitels, S.M. Submucosal neoplasms of the laryngeal introitus. J. Laryngol. Otol. 2012, 126, 706–713. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Palicelli, A.; Barbieri, P.; Mariani, N.; Re, P.; Galla, S.; Sorrentino, R.; Locatelli, F.; Salfi, N.; Valente, G. Unicystic high-grade intraductal carcinoma of the parotid gland: Cytological and histological description with clinic-pathologic review of the literature. APMIS 2018, 126, 771–776. [Google Scholar] [CrossRef] [PubMed]
  47. Palicelli, A. Intraductal carcinomas of the salivary glands: Systematic review and classification of 93 published cases. APMIS 2020, 128, 191–200. [Google Scholar] [CrossRef]
  48. Baněčková, M.; Uro-Coste, E.; Ptáková, N.; Šteiner, P.; Stanowska, O.; Benincasa, G.; Colella, G.; Vondrák, J., Jr.; Michal, M.; Leivo, I.; et al. What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases. Hum. Pathol. 2020, 103, 52–62. [Google Scholar] [CrossRef]
  49. Papagiannopoulos, P.; Raman, A.; Miller, C.; Jhaveri, M.; Ghai, R.; Husain, I. Laryngeal Paraganglioma with Chronic Cough: A Case Report. Turk. Arch. Otorhinolaryngol. 2018, 56, 233–236. [Google Scholar] [CrossRef]
  50. Palicelli, A. What do we know about the cytological features of pure intraductal carcinomas of the salivary glands? Cytopathology 2020, 31, 185–192. [Google Scholar] [CrossRef]
  51. Santandrea, G.; Piana, S.; Valli, R.; Zanelli, M.; Gasparini, E.; De Leo, A.; Mandato, V.D.; Palicelli, A. Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature. Diagnostics 2021, 11, 199. [Google Scholar] [CrossRef]
  52. Palicelli, A.; Bonacini, M.; Croci, S.; Magi-Galluzzi, C.; Cañete-Portillo, S.; Chaux, A.; Bisagni, A.; Zanetti, E.; De Biase, D.; Melli, B.; et al. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables. Cells 2021, 10, 3166. [Google Scholar] [CrossRef]
  53. De Leo, A.; Santini, D.; Ceccarelli, C.; Santandrea, G.; Palicelli, A.; Acquaviva, G.; Chiarucci, F.; Rosini, F.; Ravegnini, G.; Pession, A.; et al. What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors. Diagnostics 2021, 11, 697. [Google Scholar] [CrossRef] [PubMed]
  54. Wing-Cheuk Wong, R.; Palicelli, A.; Hoang, L.; Singh, N. Interpretation of p16, p53 and mismatch repair protein immuno-histochemistry in gynaecological neoplasia. Diagn. Histopathol. 2020, 26, 257–277. [Google Scholar] [CrossRef]
  55. Kaleta, M.; Wakulińska, A.; Karkucińska-Więckowska, A.; Dembowska-Bagińska, B.; Grajkowska, W.; Pronicki, M.; Łastowska, M. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas. Diagn. Pathol. 2019, 14, 103. [Google Scholar] [CrossRef] [Green Version]
  56. Agarwal, S.; Bychkov, A.; Jung, C.K. Emerging Biomarkers in Thyroid Practice and Research. Cancers 2021, 14, 204. [Google Scholar] [CrossRef] [PubMed]
  57. Guo, T.; Wei, R.; Dean, D.C.; Hornicek, F.; Duan, Z. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma. Biosci. Rep. 2022, 5, BSR20212446. [Google Scholar] [CrossRef] [PubMed]
  58. Koo, M.; Natkunam, Y. ERG Immunoreactivity in Blastic Hematolymphoid Neoplasms: Diagnostic Pitfall in the Workup of Undifferentiated Malignant Neoplasms. Appl. Immunohistochem. Mol. Morphol. 2022, 30, 42–48. [Google Scholar] [CrossRef]
  59. Sivasubramaniam, P.; Tiegs-Heiden, C.A.; Sturgis, C.D.; Hagen, C.E.; Hartley, C.P.; Thangaiah, J.J. Malignant gastrointestinal neuroectodermal tumor: Cytologic, histologic, immunohistochemical, and molecular pitfalls. Ann. Diagn. Pathol. 2021, 55, 151813. [Google Scholar] [CrossRef]
  60. Wang, Y.; Li, J.; Tian, Z.; Zhu, Y. Clinicopathologic features and molecular spectrum of spindle cell and sclerosing rhabdomyosarcomas in the head and neck region. Int. J. Clin. Exp. Pathol. 2018, 11, 3436–3444. [Google Scholar]
  61. Folpe, A.L.; Graham, R.P.; Martinez, A.; Schembri-Wismayer, D.; Boland, J.; Fritchie, K.J. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: A potential diagnostic pitfall. Hum. Pathol. 2018, 77, 28–34. [Google Scholar] [CrossRef]
  62. Kaçar, A.; Demır, H.A.; Durak, H.; Dervışoğlu, S. Spindle cell rhabdomyosarcoma displaying CD34 positivity: A potential diagnostic pitfall; report of two pediatric cases. Turk. Patoloji Derg. 2013, 29, 221–226. [Google Scholar] [CrossRef]
  63. Tomaszewski, M.M.; Lupton, G.P. Unusual expression of S-100 protein in histiocytic neoplasms. J. Cutan. Pathol. 1998, 25, 129–135. [Google Scholar] [CrossRef] [PubMed]
  64. Dwarakanath, S.; Lee, A.K.; Delellis, R.A.; Silverman, M.L.; Frasca, L.; Wolfe, H.J. S-100 protein positivity in breast carcinomas: A potential pitfall in diagnostic immunohistochemistry. Hum. Pathol. 1987, 18, 1144–1148. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Palicelli, A.; Ramponi, A.; Valente, G.; Boldorini, R.; Balbo Mussetto, A.; Zanelli, M. S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice. Diagnostics 2022, 12, 892. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12040892

AMA Style

Palicelli A, Ramponi A, Valente G, Boldorini R, Balbo Mussetto A, Zanelli M. S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice. Diagnostics. 2022; 12(4):892. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12040892

Chicago/Turabian Style

Palicelli, Andrea, Antonio Ramponi, Guido Valente, Renzo Boldorini, Annalisa Balbo Mussetto, and Magda Zanelli. 2022. "S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice" Diagnostics 12, no. 4: 892. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12040892

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop